US Patent 7625741 None

Patent 7625741 was granted and assigned to Intralytix on December, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Intralytix

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

76257410

Patent Inventor Names

Gary R. Pasternack0

Alexander Sulakvelidze0

Date of Patent

December 1, 2009

Patent Application Number

119551760

Date Filed

December 12, 2007

Patent Primary Examiner

‌

Gary B. Nickol

Patent abstract

The present invention is directed to isolated bacteriophage having strong lytic activity against strains of E. coli O157:H7, and methods of using that bacteriophage, and/or progeny or derivatives derived therefrom, to control the growth of E. coli O157:H7 in various settings.